Prostate Cancer Clinical Updates and Treatment Advances - ESMO 2023 Highlights

Learn about the latest prostate cancer clinical updates from ESMO 2023 in this 29-minute presentation by the Lank Center for Genitourinary Oncology. Explore key developments including Luutium treatments, overall survival rates, NCP study findings, PSM MOA4 research, advancements in immunotherapy, and AntiPD1 therapy developments. Gain insights through a comprehensive discussion of the ZYD study and participate in an interactive Q&A session that addresses critical questions in prostate cancer treatment and research.